# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions.
- Reuters
On September 3, 2024, the Board of Directors of the Company approved the appointment of Joel Grade, the Company’s Executive Vic...
Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all see...
Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, ...
The transaction is expected to close in late 2024 or early 2025, subject to receipt of customary regulatory approvals and satis...
For 2025, the company anticipates an adjusted operating margin of approximately 16.5% on a continuing operations basis, which r...